Suchergebnisse - "Cui, Xiaoteng"

PubPharm (46)

1

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma

enthalten in: Cancer letters | 2024

von Yang, E. | Hong, B. | Wang, Y. | +8

2

Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma

enthalten in: CNS neuroscience & therapeutics | 2024

von Xiao, M. | Cui, X. | Xu, C. | +10

3

Stressing the Role of CCL3 in Reversing the Immunosuppressive Microenvironment in Gliomas

enthalten in: Cancer immunology research | 2024

von Cui, X. | Kang, C.

4

Levetiracetam : A Potent Sword against Microglia Polarization in Gliomas

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Cui, X. | Wang, Q. | Liu, X. | +1

5

RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma

enthalten in: Cell death & disease | 2024

von Cui, X. | Huo, D. | Wang, Q. | +6

6

EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma

enthalten in: Neuro-oncology | 2024

von Hong, B. | Yang, E. | Su, D. | +15

ErratumIn: Neuro Oncol. 2023 Dec 8;25(12):2306-2308. - PMID 37931238

7

Small molecule compound EPIC-1042, pharmaceutical composition, and preparation method and application of small molecule compound EPIC-1042

enthalten in: Europäisches Patentamt | 2024

von KANG CHUNSHENG | HONG BIAO | WANG QIXUE | +2

8

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma

enthalten in: Cancer communications (London, England) | 2023

von Cui, X. | Zhao, J. | Li, G. | +15

9

EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT

enthalten in: Neuro-oncology | 2023

von Xin, L. | Tan, Y. | Zhu, Y. | +12

10

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance

enthalten in: Cancer biology & medicine | 2023

von Zhou, J. | Tong, F. | Zhao, J. | +6

1
2
3
4
5
Nächster »
[5]